Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1979;57(1):45–49.

Adverse reactions to rifampicin

D J Girling, K L Hitze
PMCID: PMC2395744  PMID: 311712

Abstract

This summary of adverse reactions to rifampicin has been prepared with the intention that it will be made available to all those involved in the administration of rifampicin in tuberculosis and leprosy control programmes. The reactions covered comprise those to both daily and intermittent administration, namely cutaneous and gastrointestinal reactions, hepatitis, and thrombocytopenic purpura, and those to intermittent administration only, namely ”flu” syndrome, shock, shortness of breath, haemolytic anaemia, and renal failure.

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Girling D. J. Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother. 1977 Mar;3(2):115–132. doi: 10.1093/jac/3.2.115. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES